Viewing Study NCT03651128

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:37 AM
Ignite Modification Date: 2026-03-06 @ 10:09 PM
Study NCT ID: NCT03651128
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2022-12-15
First Post: 2018-08-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)
Sponsor: Celgene
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Myeloma View
None bb2121 View
None Relapsed and Refractory Multiple Myeloma View
None High Risk Multiple Myeloma View